CYP24A1 and Hypercalcemia: Intravenous hydration has been used as a treatment approach for several women with pathogenic CYP24A1 mutations during pregnancy and postpartum, but although this treatment is generally safe and efficient for treatment of hypercalcemia, risk of volume overload (edema) should be kept in mind [32].